Pretraga
Rezultati
Assessment of risk factors for venous thromboembolism in women with breast carcinoma [2012]
Kovac, Zeljko; Kovač, MirjanaTime in therapeutic range and complications of antithrombotic treatment [2012]
Radovic, Pavica; Kovacev, Jelena B; Novakovic-Anucin, Sladjana L; Gnip, Sanja; Canak, Visnja B; Mitic, Gorana PSafety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials
[2025]
Ortega-Paz, Luis; ...; Potpara, Tatjana S. C0221: Genotype CYP2C19 Effects on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis
[2014]
Backović, Dušan Decoding risk for thromboembolic events in lymphoma patients
[2016]
Antić, Darko The c20068t gene variant in the 3 ' end of the prothrombin gene is the risk factor for recurrent pregnancy loss [2014]
Pruner, IvaAssociation Between Reticulated Platelets and Antiplatelet Therapy Response in Diabetic Patients [2014]
Mijovic, Romana; Kovacevic, Nada; Zarkov, Marija GClinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center [2017]
Gindele, Reka; ...; Mitic, Gorana P; Kovac, Mirjana KThrombosis lymphoma score performance in female population
[2017]
Antić, Darko A. Determining Therapeutic Range for Activated Partial Thromboplastin Time for Unfractionated Heparin in the Treatment of Venous Thromboembolism [2016]
Novakovic-Anucin, Sladjana L; Savic, J; Gnip, Sanja; Canak, Visnja B; Vuckovic, Biljana AFilteri
Po tipu
- 84